EFFECT OF PUMPKIN (CUCURBITA PEPO L.) AND MARIGOLD (TAGETES PATULA L.) EXTRACTS ON HIPPOCAMPAL MITOCHONDRIA FUNCTIONAL ACTIVITY WITHIN CONDITIONS OF EXPERIMENTAL ACUTE BRAIN HYPOMETABOLISM
- Authors: Voronkov A.V.1, Pozdnyakov D.I.1, Adzhiakhmetova S.L.1, Chervonnaya N.M.1, Miroshnichenko K.A.1, Sosnovskaya A.V.1, Chereshkova E.I.1
-
Affiliations:
- Pyatigorsk Medical and Pharmaceutical Institute - branch of Volgograd State Medical University
- Issue: Vol 7, No 4 (2019)
- Pages: 198-207
- Section: Articles
- URL: https://journals.rcsi.science/2307-9266/article/view/111602
- DOI: https://doi.org/10.19163/2307-9266-2019-7-4-198-207
- ID: 111602
Cite item
Full Text
Abstract
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
A. V. Voronkov
Pyatigorsk Medical and Pharmaceutical Institute - branch of Volgograd State Medical University
Email: prohor77@mail.ru
D. I. Pozdnyakov
Pyatigorsk Medical and Pharmaceutical Institute - branch of Volgograd State Medical University
Email: pozdniackow.dmitry@yandex.ru
S. L. Adzhiakhmetova
Pyatigorsk Medical and Pharmaceutical Institute - branch of Volgograd State Medical University
Email: similla503@mail.ru
N. M. Chervonnaya
Pyatigorsk Medical and Pharmaceutical Institute - branch of Volgograd State Medical University
Email: nadezhda.chervonnaya@yandex.ru
K. A. Miroshnichenko
Pyatigorsk Medical and Pharmaceutical Institute - branch of Volgograd State Medical University
Email: K220436@yandex.ru
A. V. Sosnovskaya
Pyatigorsk Medical and Pharmaceutical Institute - branch of Volgograd State Medical University
Email: 88misi88@yandex.ru
E. I. Chereshkova
Pyatigorsk Medical and Pharmaceutical Institute - branch of Volgograd State Medical UniversityReferences
- Gao C., Chang P., Yang L. Neuroprotective effects of hydrogen sulfide on sodium azide-induced oxidative stress in PC12 cells. // Int J Mol Med. - 2018. - т. 41, №1. - С. 242-250. doi: 10.3892/ijmm.2017.3227
- Takahashi R.H., Nagao T., Gouras G.K. Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer’s disease // Pathol Int. - 2017. - №67. - С. 185-193. doi: 10.1111/pin.12520.
- Chen G.F., Xu T.H., Yan Y. Amyloid beta: structure, biology and structure-based therapeutic development // Acta Pharmacol Sin. - 2017. - т. 38, №9. - С. 1205-1235. doi: 10.1038/aps.2017.28
- Lesné S.E., Sherman M.A., Grant M. Brain amyloid-β oligomers in ageing and Alzheimer’s disease // Brain. - 2013. - т. 136, ч. 5. - С. 1383-1398. doi: 10.1093/brain/awt062
- Mattson M.P. Pathways towards and away from Alzheimer’s disease // Nature. - 2004. - т. 430, №7000. - С. 631-639. doi: 10.1038/nature02621.
- Del Prete D., Suski J.M., Oulès B. Localization and Processing of the Amyloid-β Protein Precursor in Mitochondria-Associated Membranes // J Alzheimers Dis. - 2017. - т. 55. №4. - С. 1549-1570. doi: 10.3233/JAD-160953
- Lustbader J.W., Cirilli M., Lin C., Xu H.W., Takuma K., Wang N., Caspersen C., Chen X., Pollak S., Chaney M., et al. Abad directly links a beta to mitochondrial toxicity in Alzheimer’s disease // Science. - 2004. - № 304. - С. 448-452. doi: 10.1126/science.1091230.
- Chen X., Yan S.D. Mitochondrial abeta: A potential cause of metabolic dysfunction in Alzheimer’s disease // IUBMB Life. - 2006. - №58. - С. 686-694. doi: 10.1080/15216540601047767.
- De Strooper B., Iwatsubo T., Wolfe M.S. Presenilins and γ-secretase: structure, function, and role in Alzheimer Disease // Cold Spring Harb Perspect Med. - 2012. - т. 2, №1. - С. a006304. doi: 10.1101/cshperspect.a006304
- Zhao Y., Zhang Y., Pan F. The effects of EGb761 on lipopolysaccharide-induced depressive-like behaviour in C57BL/6J mice // Cent Eur J Immunol. - 2015. - т. 40, №1. - С. 11-17. doi: 10.5114/ceji.2015.49427
- Гордон, Р.Я., Капралова, М.В., Годухин, О.В., Архипов, В.И. Особенности нарушений памяти у крыс после повреждения поля СА3 дорсального гиппокампа каиновой кислотой // Бюллетень экспериментальной биологии и медицины. - 2013. - т. 155, №6. - С. 771-775.
- Brouillet E., Hyman B.T., Jenkins B.G., Henshaw D.R., Schulz J.B., Sodhi P., Rosen B.R., Beal M.F.Systemic or local administration of azide produces striatal lesions by an energy impairmentinduced excitotoxic mechanism // Experimental Neurology. - 1994. - №129. - С. 175-182.
- Воронков А.В., Поздняков Д.И., Нигарян С.А., Хури Е.И., Мирошниченко К.А., Сосновская А.В., Олохова Е.А. Оценка респирометрической функции митохондрий в условиях патологий различного генеза // Фармация и фармакология. - 2019. - т. 7, №1. - С. 20-31. doi.10.19163/2307-9266-2019-7-1-20-31
- Riha P.D., Rojas J.C., Colorado R.A., Gonzalez-Lima F. Animal model of posterior cingulate cortex hypometabolism implicated in amnestic MCI and AD // Neurobiol Learn Mem. - 2008. - т. 90, №1. - С. 112-124. doi: 10.1016/j.nlm.2008.01.011
- Scheltens N.ME, van der Weijden K., Adriaanse S.M. Hypometabolism of the posterior cingulate cortex is not restricted to Alzheimer’s disease // Neuroimage Clin. - 2018. - №.19. - С. 625-632. doi:10.1016/j. nicl.2018.05.024
- Nicholson R.M., Kusne Y., Nowak L.A., LaFerla F.M., Reiman E.M., Valla J. Regional cerebral glucose uptake in the 3xTG model of Alzheimer’s disease highlights common regional vulnerability across AD mouse models // Brain Res. - 2010. - №1347. - С. 179-185. doi:10.1016/j. brainres.2010.05.084
- Chou J.L., Shenoy D.V., Thomas N., Choudhary P.K., Laferla F.M, Goodman SR.Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer’s diseaseм // Journal of Proteomics-2011. - т. 74, №4. -С. 466-479. doi: 10.1016 / j.jprot.2010.12.012.
- Li Z., Chen X., Lu W. Anti-Oxidative Stress Activity Is Essential for Amanita caesarea Mediated Neuroprotection on Glutamate-Induced Apoptotic HT22 Cells and an Alzheimer’s Disease Mouse Model. // Int J Mol Sci. - 2017. - т. 18, №8. - С. 1623. doi: 10.3390/ijms18081623
- Obulesu, M., Jhansi Lakshmi M. Apoptosis in Alzheimer’s disease: an understanding of the physiology, pathology and therapeutic avenues // Neurochemical research. - 2014. - т. 39, №12. - С. 2301-2312.
- Chételat G., Ossenkoppele R., Villemagne V.L. Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer’s disease // Brain. - 2016. №139, ч. 9. С. 2528-2539. doi: 10.1093/brain/aww159
- Sperling R., Mormino E., Johnson K. The evolution of preclinical Alzheimer’s disease: implications for prevention trials // Neuron. - 2014. - т. 84, №3. - С. 608-622. doi: 10.1016/j.neuron.2014.10.038
- Villain N., Desgranges B., Viader F. Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer’s disease // J Neurosci. - 2008. - т. 28, №24. - С. 6174-6181. doi: 10.1523/JNEUROSCI.1392-08.2008
- Cummings J., Aisen P.S., DuBois B. Drug development in Alzheimer’s disease: the path to 2025 // Alzheimers Res Ther. - 2016. - № 8. - С. 39-51. doi: 10.1186/s13195-016-0207-9.
- Henley D.B., Sundell K.L., Sethuraman G., Dowsett S.A., May P.C. Safety profile of semagacestat, a gammsecretase inhibitor: IDENTITY trial findings // Curr Med Res Opin. - 2014. - № 10. - С. 2021-2032. doi: 10.1185/03007995.2014.939167.
- Frenguelli B.G. The Purine Salvage Pathway and the Restoration of Cerebral ATP: Implications for Brain Slice Physiology and Brain Injury // Neurochem Res. - 2019. т. 44, №3. - С.661-675. doi: 10.1007/s11064-017-2386-6
- Farina B., Di Sorbo G., Chambery A.Structural and biochemical insights of CypA and AIF interaction // Sci Rep. - 2017. - т. 7, №1. - С. 1138. doi: 10.1038/s41598-017-01337-8
- Masters C.L., Selkoe D.J. Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease // Cold Spring Harb Perspect Med. - 2012. - т. 2, №6. - С. a006262. doi: 10.1101/cshperspect.a006262